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Abstract: Near-infrared spectroscopy (NIRS) is an optical technique that can measure brain tissue
oxygenation and haemodynamics in real-time and at the patient bedside allowing medical doctors
to access important physiological information. However, despite this, the use of NIRS in a clinical
environment is hindered due to limitations, such as poor reproducibility, lack of depth sensitivity and
poor brain-specificity. Time domain NIRS (or TD-NIRS) can resolve these issues and offer detailed
information of the optical properties of the tissue, allowing better physiological information to be
retrieved. This is achieved at the cost of increased instrument complexity, operation complexity
and price. In this review, we focus on brain monitoring clinical applications of TD-NIRS. A total
of 52 publications were identified, spanning the fields of neonatal imaging, stroke assessment,
traumatic brain injury (TBI) assessment, brain death assessment, psychiatry, peroperative care,
neuronal disorders assessment and communication with patient with locked-in syndrome. In all
the publications, the advantages of the TD-NIRS measurement to (1) extract absolute values of
haemoglobin concentration and tissue oxygen saturation, (2) assess the reduced scattering coefficient,
and (3) separate between extra-cerebral and cerebral tissues, are highlighted; and emphasize the
utility of TD-NIRS in a clinical context. In the last sections of this review, we explore the recent
developments of TD-NIRS, in terms of instrumentation and methodologies that might impact and
broaden its use in the hospital.
Keywords: NIRS; diffuse optics; time-domain; time-resolved; brain oxygenation; tissue saturation;
scattering; absorption
1. Introduction
Over the last two decades, the near-infrared spectroscopy (NIRS) field has gained lots of attention
as more and more instruments are used in patients within the hospitals [1]. NIRS relies on the fact
that light, in the range of 600 to 1000 nm, can penetrate deep into the biological tissue, because in that
wavelength range absorption is low, and scattering is the dominant interaction process. Moreover,
each absorber, called chromophore, has a specific absorption or extinction coefficient [2]. It is thus
possible to quantify the contribution of each chromophore and to resolve its concentration in the tissue.
One of the main chromophores in tissue that is oxygen dependent is haemoglobin; NIRS can quantify
the in vivo concentrations of oxygenated (HbO2) and deoxygenated (HHb) haemoglobin and hence
monitor tissue oxygenation non-invasively, and in real-time. Since its first introduction by Jobsis in
1977 [3], this technique has been used to probe various types of tissue, such as brain and muscle [4]
and breast [5].
From a methodological point of view, a NIRS measurement can be achieved in three different
detection modes: continuous wave (CW), frequency domain (FD), and time domain (TD). These modes
differ by their level of complexity and the amount of information that they can retrieve. We discuss
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the details of these techniques in Section 2, and Table 1 lists their main characteristics. Of those three
techniques, the CW-NIRS mode is the most widespread and has already been used extensively in the
hospitals. Indeed, several reviews can be found in the literature that discuss the use of NIRS in the
context of clinical brain monitoring. In particular, a recent review by Obrig discusses the use of NIRS in
neuroscience, and the clinical areas of cerebrovascular disease, epileptic disorders, and in the evaluation
of the functional activation of the diseased brain [6]. The use of NIRS for monitoring, traumatic brain
injury (TBI) [7] and clinical interventions, including the use of the technique in anaesthesiology [8,9],
neonatology [10] and psychiatry [11–14], have also been reviewed.
While these reviews demonstrate the potential and popularity of the NIRS technique; there
is still debate on whether NIRS can be used reliably in a clinical context. Most NIRS instruments
used in hospitals are CW devices due to their commercial availability and simplicity of operation;
however, these instruments have several limitations, mainly their lack of brain-specificity and the large
variability in absolute quantification of oxygenation [15]. TD-NIRS can resolve these issues and enable
an in-depth measurement of absolutes values (see next section). TD-NIRS technology is often viewed
as more complicated when compared to CW-NIRS and is not widely available. Indeed, the society for
functional Near Infrared Spectroscopy website lists companies providing NIRS instruments [16] and
out of the 14 companies listed, only Hamamatsu Photonics (Hamamatsu Photonics K.K., Hamamatsu,
Japan) provides commercial TD-NIRS instruments
The goal of the present work is to review the current use of TD-NIRS for clinical applications,
with a particular focus on brain monitoring. We will begin with a brief description of the NIRS basics
in terms of methodology and technology. Then, we will review the reported work on clinical brain
monitoring with TD-NIRS. Finally, we will highlight some recent TD-NIRS developments that we
believe will have a direct impact on the clinical popularity of the technique.
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Table 1. Characteristic of the three NIRS methodologies.
Appl. Sci. 2018  8, x FOR PEER REVIEW 3 of 2 
Table 1. Characteristic of the three NIRS methodologies. 
Main Characteristics 
Methodology 
CW FD TD 
Practicalities    
Instrument cost 
Depends on number of channels, from low to 
high High Very high 
Instrument size Depends on number of channels, wearable 
systems available 
Bulky but transportable Bulky but transportable 
Availability of commercial systems Yes, multiple companies Yes, but only one company Yes, but only one company 
Technical considerations    
Number of channels 
Can be very high (more than 1000) with the 
latest HD-NIRS systems. Commercial systems 
with up to 100 channels 
Can be high. Commercial 
system with up to 500 
channels 
Lowest. Usually between 1 and 30 
channels. Commercial system with 
up to 2 channels 
Sampling rate Highest: 100 Hz Middle: 50 Hz 
Lowest: 1–10 Hz (can be higher, 
depends on number of channels, 
wavelengths) 
Non-contact scanning possibilities Yes No Yes 
Depth sensitivity Low, depends on source detector distance 
Deep, depends on source 
detector distance 
Deep, do not depends on source 
detector distance 
Measurement parameters    
[HbO2], [HHb], [HbT] Yes, changes Yes, absolute but requires 
multi-distance 
Yes, absolute, even with a single 
channel 
Absolute values of absorption and 
scattering coefficients, and path length No 
Yes, but requires multi-
distance Yes 
StO2 Yes, but requires multi-distance 
Yes, but requires multi-
distance Yes 
DOT possible Yes Yes Yes 
Abbreviations: CW: continuous-wave; FD: frequency-domain; TD: time domain; StO2: tissue saturation in oxygen; DOT: diffuse optical tomography; HD-NIRS: high-
density NIRS.
Ab reviations: CW: conti uo s-wave; FD: frequ ncy-domain; TD: time domain; StO2: tissue saturation in oxyge ; DOT: diffuse optical tomogr phy; HD-NIRS: high-density NIRS.
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2. Basics of NIRS
In the wavelength range used in NIRS (i.e., 600–1000 nm), two main physical phenomena affect
the photon trajectory in tissues: scattering and absorption [17]. The scattering is the dominant effect in
biological tissue and is caused by microscopic refractive index changes inside the tissue. The resulting
effect is that the initial trajectory of the photon is lost, and the photon is deviated to another direction.
In NIRS, this quantity is represented by the reduced scattering coefficient µ′s, which represents the
scattering probability per unit length together with the average scattering direction. This parameter
can give an insight to the tissue structure [18]. On the other hand, the absorption is the consequence of
the loss of a photon which is due to the presence of particular chromophores inside the tissue that
convert light intensity into other kinds of energy, either radiative (i.e., fluorescence) or nonradiative (i.e.,
vibrational). In NIRS, this quantity is represented by the absorption coefficient µa, which represents the
absorption probability per unit length. As each chromophore has a specific spectral shape, they will
each contribute differently to the overall absorption. Then, using a multiwavelength light source with
well-chosen wavelengths s us to separate the contribution of each chromophore in order to quantify its
concentration. A more detailed explanation of those processes can be found in [17,19].
The effects of absorption and scattering contribute non-linearly to the global attenuation of the
light by the tissue. Hence, it is not straightforward to disentangle them. Indeed, an inverse problem
must be solved in order to have access to the absorption and scattering independently [20]. Basically,
light transport in tissue can be modelled accurately by the radiative transport equation (RTE) or by
the simpler diffusion equation (DE), which is derived from the RTE given certain assumptions [19].
Usually, the RTE is solved numerically using Monte Carlo (MC) approaches and gives the most accurate
description of light propagation. This accuracy comes at the cost of long calculation time [21]. The
DE can also be solved numerically, by using the finite element method (FEM). Software platforms are
available to facilitate this process include TOAST++ and NIRFAST [22,23]. However, the real strength
of the DE is that it can be solved analytically in various simple geometries [17]. Thus, the calculation
time is fast, and real-time methods can be implemented.
As mentioned in the introduction, data acquisition can be performed in three modes: CW, FD, and
TD. The principle of those acquisition modes is summarized in Figure 1. Below we describe the basics
of each technique, so the reader can appreciate their advantages and disadvantages. For further, more
detailed information we refer the reader to [24]. In all the three modes, the basic idea is to shine light
onto the tissue, and to collect the transmitted/reflected light few centimetres away from the source point.
The single point CW technique is the simplest one; a continuous light is emitted onto the tissue, and the
transmitted attenuated light is collected few centimetres away. CW-NIRS only measures the changes
in light attenuation, which is defined as the variation and reduction of the transmitted/reflected light
intensity from the emitted light. Indeed, using the change in light attenuation at several wavelengths
and assuming that light scattering has not changed between measurement time points, CW-NIRS
can calculate, using the modified Beer–Lambert law (MBLL) [25], the changes in [HbO2] and [HHb]
concentrations, which are assumed to be the sole chromophores that contributes to the contrast. The
MBLL considers the extra path length between the source and the detector due to the scattering with a
parameter named the differential path length factor (DPF). As this parameter cannot be measured by
CW systems, since they cannot distinguish absorption and scattering, this DPF is generally extracted
from tabulated values [26] or using a modelling approach [27]. This limits the quantitative accuracy of
the measurement since the overall scattering coefficients of the probed tissues is subject-dependent.
This is also the reason why single point CW-NIRS only reports changes in haemoglobin concentration.
However, some extensions of the CW technique enable us to access some absolute parameters. Indeed,
using the spatially resolved spectroscopy (SRS) technique, based on the measurement of the light
attenuation at several source/detector separations, the absolute µa of the tissue can be estimated by
fitting the distribution of the spatially resolved light attenuation measured, to the solution of the DE
in the CW regime [28]. Then, measuring the spatial distribution of the light attenuation at several
wavelengths, and assuming (1) that [HbO2] and [HHb] are the sole chromophores contributing to the
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absorption and (2) an a-priori distribution of µ′s as a function of wavelength, then one can extract
information about the absolute tissue oxygen saturation (referred as tissue oxygenation index (TOI)
or tissue saturation (StO2) in the literature) [29]. The tissue saturation reflects the ratio between the
concentration of [HbO2] and the concentration of total haemoglobin ([HbT] = [HbO2] + [HHb]). This
has been widely exploited by commercial brain oximeters [30]. Moreover, some recent developments
in CW system methodology employing a broadband spectrum can be used in order to extract absolute
optical properties of the tissue [31]. The use of a broadband spectra can also unlock information on a
third chromophore, cytochrome-c-oxidase (CCO), which is a marker of the metabolism. Therefore,
the detection of this third chromophore can refine the picture of the tissue status obtained by NIRS,
through integration of the metabolic and hemodynamic information [32].
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Figure 1. Schematic of the three NIRS detection modes. (a) TD-NIRS mode, an ultra-short light 
impulse is shined onto the tissue and the broadened and attenuated re-emitted pulse is measured 
after passing through the tissue. (b) FD-NIRS, a modulated (MHz) continuous light source is shined 
onto the tissues and the attenuated, phase shifted reemitted light is measured. (c) CW-NIRS, a 
continuous light is shined onto the tissues and the attenuated re-emitted light is measured. (d) 
Representation of the photon path in tissues for each technique. S: source, D: detector. 
Figure 1. Schematic of the thr e NIRS detection modes. (a) TD-NIRS mode, an ultr -short lig t impulse
is shined onto t e tissue and the broadened and tt uated re-emitted puls is meas red after passing
through the t ssue. (b) FD-NIRS, a modulated (MHz) continuous light source is shined onto the tissues
and the att nuated, phase shifted re mitted lig t is m asured. (c) CW-NIRS, a continuous light is
shined ont the tissues and the attenuated re-emitted light is measured. ( ) Represent tion of the
photon path in tissues for each technique. S: source, D: detector.
One of the drawbacks of NIRS is its poor spatial resolution due to the inherent properties of light
transport in tissue. This drawback can be reduced when using not only one, but several detection
channels. Indeed, more complex arrangements have been developed to give access to a topographic
(2D) or tomographic (3D) maps of brain haemoglobin concentration (referred as DOT: diffuse optical
tomo/topography). This approach has largely been exploited in functional NIRS (fNIRS), where brain
activity is being monitored [33]. Recently, the development of high-density DOT proved to have a
resolution comparable to MRI [34], marking a new cornerstone in the development of the NIRS technology.
The second NIRS technique is frequency domain NIRS (FD-NIRS). In FD-NIRS the light shined
onto the tissue is modulated at frequencies in the MHz range. The tissue will attenuate and shift the
phase of the reflected light. Analysis of the phase-shift provides information on the total distance that
the light has travelled through tissue. To solve the DE and obtain measurements of absorption and
scattering, the intensity and phase at two or more, source-detector distances is required [35]. FD-NIRS
enables the estimation of absolute brain tissue oxygen saturation and enhances depth resolution
comparable to TD-NIRS [36]. However, Davies and colleagues [37] have recently compared CW-NIRS
with FD-NIRS in monitoring clinical hypoxia, reporting that there were no advantageous difference
observed in parameters recovered from the FD-NIRS compared with those detected by CW-NIRS.
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2.1. TD-NIRS Methodology
In TD-NIRS an ultra-short light impulse (typically in the picosecond range) illuminates the tissue.
Tissue has the effect of attenuating and broadening the re-emitted pulse (the resulting pulse-width is
typically few nanoseconds wide). The measured signal is typically called a temporal point spread
function (TPSF) or distribution of time of flights (DTOFs) of photons. Indeed, the measurand here
is the histogram of the arrival time of photons. Thus, the amount of information acquired by time
resolved systems outstrips the two previous techniques since they only acquire intensity (CW-NIRS) or
intensity and phase (FD-NIRS) dimensions.
The DTOF acquired by the TD-NIRS systems contains information on the optical properties of the
tissue and enables various data processing workflows to be used. Each method has its own strengths
and drawbacks, in terms of computational cost accuracy, or need for a priori, as depicted in Figure 2.
There are three main approaches for the data processing of TD-NIRS: the fitting approach, the moment
calculation approach, and the gating approach (also called time gating or time windowing).
Appl. Sci. 2018, 8, x FOR PEER REVIEW 6 of 32 
 
One of the drawbacks of NIRS is its poor spatial resolution due to the inherent properties of light 
transport in tissue. This drawback can be reduced when using not only one, but several detection 
channels. Indeed, more complex arrangements have been developed to give access to a topographic 
(2D) or tomographic (3D) maps of brain haemoglobin concentration (referred as DOT: diffuse optical 
tomo/topography). This approach has largely been exploited in functional NIRS (fNIRS), where brain 
activity is being monitored [33]. Recently, the development of high-density DOT proved to have a 
resolution comparable to MRI [34], marking a new cornerstone in the development of the NIRS 
technology. 
The second NIRS technique is frequency domain NIRS (FD-NIRS). In FD-NIRS the light shined 
onto the tissue is modulated at frequencies in the MHz range. The tissue will attenuate and shift the 
phase of the reflected light. Analysis of the phase-shift provides information on the total distance that 
the light has travelled through tissue. To solve the DE and obtain measurements of absorption and 
scattering, the intensity and phase at two or more, source-detector distances is required [35]. FD-NIRS 
enables the estimation of absolute brain tissue oxygen saturation and enhances depth resolution 
comparable to TD-NIRS [36]. However, Davies and colleagues [37] have recently compared CW-
NIRS with FD-NIRS in monitoring clinical hypoxia, reporting that there were no advantageous 
difference observed in parameters recovered from the FD-NIRS compared with those detected by 
CW-NIRS.  
2.1. TD-NIRS Methodology 
In TD-NIRS an ultra-short light impulse (typically in the picosecond range) illuminates the 
tissue. Tissue has the effect of attenuating and broadening the re-emitted pulse (the resulting pulse-
width is typically few nanoseconds wide). The measured signal is typically called a temporal point 
s read function (TPSF) or distribution of time of flights (DTOFs) of photons. Indeed, the measurand 
here is the histogram of the arrival time of p otons. Thus, the amount of information acquired by 
tim  resolved systems outstrips th  two previous techniques since they only cquire intensity (CW-
NIRS) or int nsity and has  (FD-NIRS) dimensions. 
The DTOF cquired by the TD-NIRS systems contains information on the optical properties of 
the tissue and enables various data processing workflows to be used. Each method has it  wn 
strengths a d drawbacks, in terms of computational c st accuracy, or ne d for a priori, as depicted 
i  Figure 2. There are three main approaches for the d ta processing of TD-NIRS: th  f tting approach, 
t  moment calcul tion pproach, and the gating approach (also called time gating or time 
windowi g). 
 
Figure 2. Schematic of the three-data processing approach in TD-NIRS. i r . i r i - I S.
The fitting approach. This approach was the first to be used to process TPSF data [38]. It consists of
minimising the different between an analytical solution of the DE for a particular geometry, and the
measured TPSF. Typically, a non-linear fitting procedure based on the classical Levenberg–Marquardt
approach is used in order to determine tissue µa and µ′s [39]. Different geometry can be assumed, the
most commonly used being the homogeneous semi-infinite one, notably for its simplicity [38]. However,
assuming that the head is completely homogeneous might appear an over simplification. More accurate
tissue geometries can be considered, such as the multi-layered geometry, that represents more accurately
the brain geometry [40]. For example, one could considerer an extra-cerebral and an intra-cerebral
layer. As mentioned earlier, FEM and MC methods can also be used to model-specific anatomies which
provides the best accuracy. Once the absorption coefficient is known at several wavelengths, the absolute
concentration of each chromophore considered can be calculated using the Beer–Lambert Law. Typically,
the considered chromophores are HbO2, HHb and water. The water content is usually set to 80% and the
free fitting parameters are [HbO2] and [HHb] [41]. The tissue saturation can then be extracted from those
concentrations. It worth mentioning that no assumption of µ′s is needed here as it is calculated.
It worth mentioning that in all TD-NIRS measurements, the contribution of the instrument to
the DTOF has to be taken into account by measuring what is called the instrument response function
(IRF). The ability to deconvolute the IRF from the tissue response function is crucial in order to retrieve
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accurate data [42]. This deconvolution step is non-trivial and the standard approach when fitting the
data is to minimise the error between the TPSF and the model convoluted by the IRF [43].
The moments calculation. This approach reduces the amount of information contained in the entire
DTOF by calculating 3 metrics, the 0th order moment corresponding to the total number of photons
(equivalent to CW), the 1st order moment corresponding to the mean arrival time of photon (i.e., used
to calculate the DPF (see refs. [26,44])), and the second-order moment corresponding to the variance of
the TPSF [45]. Thus, it reduces the computational cost of the calculation. Moreover, the deconvolution
of the TPSF is made easier since the deconvolution process only requires subtraction of the moments of
the IRF from the moments of the TPSF.
Analytical expressions based on these moments are available in order to determine the absorption
and scattering coefficients [45]. Once the optical properties are known, the same process as described
for the fitting approach can be applied to the haemoglobin concentrations and tissue saturation. Finally,
it has been shown that this approach can enhance the depth sensitivity of the measurements, since
these three metrics have different depth-sensitivity [46].
The gating (or time gated approach). This approach is based on the separation of the TPSF in different
time gates, representing different arrival time of photons. Usually, one can separate an early and a
late gate, the early gate being more sensitive to the superficial layers, and the late gate to the deep
tissues [47]. This effect is illustrated in supplementary material 1, which shows a video of the change
of absorption sensitivity (x, y) as function as the position of the gate in the TPSF. It shows clearly that
the late gates are more sensitive to deep tissues [48]. This technique has been used with systems based
on ICCD cameras [49,50] or, more recently, SPADs [51].
2.2. Measure of Brain Perfusion
Finally, it worth mentioning that all the approaches described above rely on the fact that the
changes in absorption are due to endogenous oxygen-dependent contrast (i.e., haemoglobin). This
principle is at the heart of the NIRS technique as it enables us to follow the blood volume (i.e., via
HbT), and StO2, which reflects the balance between the oxygen delivery and the oxygen consumption.
This implies that NIRS cannot directly measure the cerebral perfusion. However, this parameter can be
assessed by using alternative methodologies and instruments.
Indeed, the use of indocyanine green (ICG), a contrast enhancing agent, makes the assessment
of cerebral perfusion with NIRS possible. ICG is a non-toxic light-absorbing dye that has a high
absorption and fluorescence emission in the NIR [52]. By following the transit time of an ICG bolus
injected intravenously, one can estimate the cerebral blood flow (CBF) [53]. Although, this transit time
can be monitored in depth with DOT-CW-NIRS systems [52], it has been showed that when using
only one channel, the use of TD-NIRS enhances the depth sensitivity of the ICG bolus tracking and
enables us to distinguish between intra- and extra-cerebral layers. Moreover, the use of TD-NIRS
gives also access to the measurement of the fluorescence signal of the ICG, which also increase the
depth sensitivity [54]. The measured signal of fluorescence is often referred to as the distributions of
times of arrival of fluorescence (DTAs). The main advantage of this technique is that it can provide a
CBF value in standard physiological units (i.e., mL of blood/100 g/min) [55]. The main drawback of
this technique is that it cannot continuously monitor the CBF as the injection of ICG is limited by a
maximum recommended daily dose. We will then refer to this technique as DCE-TD-NIRS, where
DCE stands for dynamic contrast enhanced.
On the other hand, diffuse correlation spectroscopy (DCS) is a technique that enables continuous
monitoring of a CBF index called blood flow index (BFI) without the injection of a contrast agent.
Briefly, in DCS, the tissue of interest is illuminated by coherent near-infrared light, which causes a
speckle interference pattern to form after the light scatters multiple times through the tissue. Thus, the
changes in light scattering due to the moving red blood cells causes the speckle pattern to fluctuate
rapidly. Those speckle patterns are then analysed to extract blood flow information. In order to
quantify the fluctuation of the speckle pattern, the optical properties of the tissue need to be assumed
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or measured. Therefore, the use of TD-NIRS is well-suited to provide such information, especially
since the two techniques are compatible and can be combined. A more detailed explanation of DCS
principles can be found in [56].
3. Clinical Brain Monitoring with TD-NIRS
The focus if the present review was to evaluate the use of TR-NIRS in a clinical context regarding brain
monitoring. Therefore, papers were identified using PubMed and Scopus, searching for a combination
of keywords including (near-infrared spectroscopy | near infrared | optical | tomography) and (time
domain | time resolved) and (brain | cerebral). Moreover, a manual search from articles’ references was
performed and authors related to the subject were contacted. Papers were rejected if only CW-NIRS or
FD-NIRS were used, if the application was not focused on the brain, and if no clinical application could
be identified (i.e., applications on healthy volunteers or animals only). A total of 52 publications covering
a variety of applications were identified. We have grouped the applications into seven subgroups that
we will discuss below: neonatal applications (19 studies), stroke assessment (8 studies), traumatic brain
injury (TBI) assessment (four studies), psychiatry (nine studies), brain death assessment (three studies),
perioperative care assessment (seven studies), and other applications (two studies).
Table 2 provides a summary of the main characteristics of the instrument used in the studies
reported in this review, and Figure 3 shows pictures of the instrumentation typically used. A more
detailed list of TD-NIRS instruments is available in the review by Torricelli and colleagues [57].
Moreover, a summary of the studies included in this review is presented in Table 3 and includes the
system used, the number of patients scanned, the methodology used to process the data, and finally
states the measurand reported in these studies.Appl. Sci. 2018, 8, x FOR PEER REVIEW 9 of 32 
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Figure 3. Example of homemade and commercial TD-NIRS instrumentation. (a) Homemade TD-NIRS
system used in [58], used with ICG. (b) The tNIRS-1 commercial system, from Hamamatsu (Japan),
courtesy of Hamamatsu. (c) Example of probe positioning over both cerebral hemispheres of a patient
(the system is the one illustrated in (a)). Extracted from [58].
Finally, Figure 4 summarizes the main characteristic of the TD-NIRS systems used in the reviewed
publications and shows the number of publications over the last 20 years that report the use of TD-NIRS
in a clinical context.
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Table 2. List of the system used in the publication reviewed, with their principle characteristics.
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1 Hamamatsu Photonics K.K. TRS-10 3 761, 795, 835 nm 5 Laser diode PMT 1 0.2 
2 Hamamatsu Photonics K.K. TRS-20 3 759,797,833 5 Laser diode PMT 2 0.2 
3 Hamamatsu Photonics K.K. TRS-21 6 
762, 802, 838, 908, 
936, 976 nm 
5 Laser diode PMT 2 0.2 
4 Hamamatsu Photonics K.K. tNIRS-1 3 755, 826, 850 nm 9 Laser diode MPPC 2 0.2 
5 Hamamatsu Photonics K.K. NIRO-TRS 1 3 755, 826, 850 nm 9 Laser diode MPPC 2 0.2 
6 
Standford University, 
Standford, USA 
NA 2 785, 850 nm NA Laser diode PMT 34 >0.05 
7 UCL, London, UK MONSTIR 2 780, 815 nm 40 Ti:sapphire laser MCP-PMT 32 < 0.05 
8 UCL, London, UK MONSTIR II 4 
690, 750, 800, 850 
nm 
40 
Supercontinuum 
laser 
PMT 32 ≈ 0.01 
9 
Politecnico di Milano, Milan, 
Italy 
NA 2 690, 820 nm 80 Laser diode PMT 24 1 
10 * BabyLux project BabyLux 3 685, 760, 822 nm 20 Laser diode hybrid PMT 1 1 
11 
Physikalisch-Technische 
Bundesanstalt, Berlin, Germany 
NA 2 803, 807nm 60 Laser diode PMT 4 20 
12 
Physikalisch-Technische 
Bundesanstalt, Berlin, Germany 
NA 1 785 nm 50 Laser diode PMT 8 20 
13 
Physikalisch-Technische 
Bundesanstalt, Berlin, Germany 
NA 3 687, 803, 826 nm 45 Laser diode PMT 4 0.4 
14 
Politecnico di Milano, Milan, 
Italy 
NA 3 690, 785, 830 nm 80 Laser diode hybrid PMT 1 0.03 
15 
Institute of Biocybernetics and 
Biomedical Engineering, 
Warsaw, Poland 
NA 2 687, 832 nm 80 Laser diode PMT 32 10 
16* 
University of Pennsylvania, 
Philadelphia, Pennsylvania, 
USA 
NA 7 
730, 750, 786, 810, 
830, 850, 808 nm 
78 
Supercontinuum 
laser 
hybrid PMT 1 0.9 
17 
Institute of Biocybernetics and 
Biomedical Engineering, 
Warsaw, Poland 
NA 1 760 nm 80 Laser diode PMT 8 10 
18 
Western University, London, 
Ontario, Canada 
NA 2 760, 830 nm 80 Laser diode hybrid PMT 4 3.33 
* Systems 10 and 16 also have DCS instrumentation. Here only the TD-NIRS part is reported. Refer to [59,60] respectively for complete instrumental details.       
** Typical values than can vary depending on the instrument settings. See individual references for more details. Abbreviations: PMT: photomultiplier tube; MCP-
PMT: microchannel plate PMT; MPPC: multi-pixel photon counters. 
* Systems 10 and 16 also have DCS instrumenta ion. Here only the TD-NIRS part is reported. Refer to [59,60] respectively for complete instrumental details. ** Typical v lues than can vary
depending on the instrument settings. See individual references for more details. Abbreviations: PMT: photo ultiplier tube; MCP-PMT: microchannel plate PMT; MPPC: multi-pixel
photon counters.
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3.1. Neonatology
The use of TD-NIRS in eonatology is t that has been one of the most explored, starting
from the very early days of TD-NIRS. This partic lar population is well-suited to NIRS, allowing
DOT to be performed [61]. Indeed, the first papers reporting the use of an in-house developed
TD-NIRS instrument (ID: 6 in Table 2) on neonates dates from the late 1990s, by the group of
Dr. David Benaron at Stanford University, USA. In a series of papers [62–65], they reported the first
tomographic images of neonates using TD-NIRS. This team then successfully tomographically-identified
intracranial haemorrhage [62,63] and focal regions of low oxygenation after acute stroke [65]. Hintz
and c lleagues [66] also retrieved a t pographic image of the activation of the motor cortex of one
infant measured at ix days postnatal age.
At University College London (UCL), UK, an in-house 32 channel TD-NIRS system was developed.
This system was called MONSTIR (for Multi-channel Opto-electronic Near-infrared System for
Time-resolved Image Reconstruction) [67,68]. With this system, tomographic images of healthy infants [69]
and infants with intraventricular haemorrhage (IVH) [69,70] were reconstructed. An example of their
reconstructed images is provided in Figure 5a. The image reconstruction required a comparison of the
in-vivo data with the data acquired on a phantom with well-known optical properties, producing an image
of the differences. The natural extension of this work was to be able to reconstruct images without the
necessity to image a reference phantom. Hebden and colleagues [71] first demonstrated this possibility on
a severely brain-injured 38-week-old newborn. The changes in absorption and scattering coefficient, and
in [HbO2] and [HHb], resulting from small alterations in ventilator settings could be detected during an
imaging session of three hours at two wavelengths. Following that, Gibson and colleagues [72], reported
the first 3D optical images of entire pre-term babies’ heads during motor-evoked response. More recently,
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the UCL team reported the development of the second generation of the TD-DOT-NIRS MONSTIR, called
MONSTIR II [68]. Dempsey and colleagues [73] reported to have successfully scanned a healthy infant
with MONSTIR II. This work was largely exploratory to demonstrate the quality of the recording of the
data acquired with MONSTIR II in a clinical environment. Moreover, in her PhD thesis [74], Dempsey
reported the use of moments to reconstruct images of babies presenting with perinatal arterial ischemic
stroke (PAIS). Here, she explored the possibility of using the calculated moments (intensity, time of flight,
variance) as a metric to locate the stroke area.
In the literature there is a significant amount of publications using commercial TD-NIRS systems
developed by Hamamatsu in neonates. Koyano and colleagues [75] investigated the effect of blood
transfusion on cerebral haemodynamic in preterm infants using a TRS-10 system, suggesting that
TD-NIRS can be used for determining the need for transfusion in very-low-birth-weight infants. Ishii
and colleagues [76] used a TRS-20 system to compare changes in cerebral and systemic perfusion
between appropriate- and small-for-gestational-age (AGA and SGA, respectively) infants during the
first three days after birth. Also using a TRS-20, Fujioka and colleagues [77] reported the difference in
brain oxygenation between term and preterm infants during the first three days of life.
Nakamura and colleagues [78] used a TRS-10 system to measure StO2 and [HbT] in babies with
hypoxic-ischemic encephalopathy (HIE), reporting that neonates with adverse outcomes had higher
values within 24 h after birth compared with neonates with a favourable outcome. Additionally, using
a TRS-10 system, Hoshino and colleagues [79] reported the changes in oxygenation concentration and
tissue saturation before and after an endovascular treatment in a 10 months old patient.
Lastly, some work has been done in order to evaluate normal values of optical properties and
physiological parameters in neonates. Ijichi and colleagues [80] used a TRS-10 to investigate both
the optical properties and relevant physiological parameters of a population of 22 neonates. They
reported the absorption and reduced scattering coefficient, DPF, total haemoglobin concentration and
tissue saturation, together with the blood volume. They also showed the relationship between those
parameters and the gestational age. The use of the TD-NIRS is highlighted here, with the potential to give
detailed information about µa and µ′s, and physiological parameters. Spinelli and colleagues [81] used
an in-house developed instrument (ID: 9 in Table 2) to evaluate the optical properties and haemoglobin
parameters of 33 neonates. They found consistencies in the measures of blood oxygenation but variations
in the µa, similar to adult population [82]. They concluded that more work was needed to properly
define standard values. Finally, preliminary results from a combined TD-NIRS/DCS system reported
the evaluation of µa, µ′s and StO2, together with the BFI of 21 babies, using the BabyLux system [59].
3.2. Stroke Assessment
The utility of using NIRS technology in the context of stroke has been reviewed by Obrig and
Steinbrink in 2011 [83]. In that review, they concluded that using TD-NIRS is mandatory for the
assessment of pathophysiological state-dependent variables such as perfusion or absolute values of
tissue oxygenation. The first works reporting the use of TD-NIRS on stroke patients was by Liebert
and colleagues [84,85]. In these studies, the cerebral perfusion was measured by using the method
of DCE-TD-NIRS. The bolus transit time through intra- and extra-cerebral tissue was measured in
both hemispheres of two stroke patients, using an in-house developed multichannel TD-NIRS system
(ID: 11 in Table 2). Steinkellner and colleagues [86] also reported the use of DCE-TD-NIRS to measure
the cerebral perfusion in 10 acute stroke patients using an in-house developed multichannel TD-NIRS
system (ID: 12 in Table 2). The authors reported to have used the kinetics of the moments to follow the
kinetics of the ICG bolus. The kinetic difference between the affect and unaffected hemisphere was
compared. The analysis of the variance enabled them to substantially reduce the movement artefacts
and to follow the intracerebral compartment, compared to the traditional signals acquired with CW
systems, which have been simulated here by time integrating the TPSF (illustrated in Figure 5b).
Using the variance, the authors reported a clear difference in perfusion between the affected and
non-affected hemisphere.
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Other groups reported the use of an in-house developed system to follow the brain oxygenation
of stroke patients. Leistner and colleagues [87] compared the neurovascular coupling, induced by a
simple motor test, between six patients with subacute ischemic stroke and four healthy volunteers.
In this study, the neurovascular coupling was measured using a DC-MEG and a TD-NIRS system (ID:
13 in Table 2) simultaneously. Another in-house developed TD-NIRS system (ID: 14 in Table 2) was
used by Giacalone and colleagues [88] to measure haemoglobin concentrations and StO2 of the anterior
circulation in stroke patients. In this study, 47 stroke patients were monitored in the stroke unit at
the bedside. Multiple areas of the brain were probed (i.e., frontal, parietal, occipital) and CT-scans
images were used to categorize brain regions below each TD-NIRS probe. Moreover, the results were
compared with a group of 35 controls selected from a previous study reported in [82]. Significant
differences of haemoglobin concentrations and StO2 were found between patients and controls, and
among patients according to recanalization status.
Finally, commercial Hamamatsu TD-NIRS systems were also used on stroke patients. Yokose
and colleges [89,90] reported the detection of vasospasm in patients with aneurismal subarachnoid
haemorrhage (SAH). Another study by Sato and colleagues [91] used a TRS-20 system to measure
haemoglobin concentrations, StO2, and optical path length of five patients suffering from chronic stroke.
They compared the results between the unaffected and affected hemisphere. Significant differences
between the unaffected and affected hemisphere were found for StO2 (higher in the affected side),
[HHb] (higher in the affected side) and optical path length (longer in the affected side).
3.3. Traumatic Brain Injury (TBI) Assessment
The use of NIRS technology in traumatic brain injury (TBI) has been reviewed by Davies and
colleagues in 2015 [92]. Here we explicitly review and discuss the use of TD-NIRS systems in the same
patient population. We found three recent studies investigating the brain status of TBI patients. Weigl
and colleagues [58], used the DCE-TD-NIRS method to assess cerebral perfusion in 26 TBI patients and
nine controls, using an in-house developed multichannel TD-NIRS system (ID: 15 in Table 2). In this
study, the moments of the DTOFs and DTAs were calculated, and their time courses were compared,
to track the ICG bolus. Statistically significant differences between the time courses of the ICG bolus
calculated using the different moment parameters obtained in healthy subjects and patients with brain
haematoma and brain oedema were observed. Moreover, it was noted that the best optical parameter
to differentiate between patients and controls was the variance of DTOFs and DTAs.
Highton and colleagues [93] focused on the changes in light scattering related to TBI. In this study,
a total of 21 TBI patients were monitored with a TRS-20 system. In 10 patients suffering from unilateral
infarction, even though no significant difference in cerebral saturation or haemoglobin concentration
were found, a significant reduction of µ′s was related to the injury severity.
Finally, He and colleagues [60] used an in-house developed TD-NIRS and DCS system (ID: 16 in
Table 2) to continuously monitor the absolute blood flow (i.e., using physiological units, see Section 2)
of seven patients with acute brain injury. This absolute assessment was possible by coupling the
DCE-TD-NIRS, to extract absolute values, and DCS, to continuously assess the blood flow. Here
patients were monitored 8 h a day, four days. This illustrates the use of state-of-the-art TD-NIRS
technology and instrumentation to collect information with comprehensive units for a physician.
3.4. Brain Assessement in Death
TD-NIRS could also be used to assess the adequacy of resuscitation. In a pilot study, Lanks
and colleagues [94] used a NIRO-TRS1 Hamamatsu system to monitor the cerebral saturation and
haemoglobin concentration in 11 patients with septic shock, and compared those measurements
with traditional markers of perfusion adequacy. In another study using the same system, Lanks
and colleagues [95] reported the case of a young man who suffered a pulseless electrical activity
(PEA) arrest (i.e., cardiac arrest) while cortical oxygenation was monitored. The onset of cortical
deoxygenation preceded the loss of palpable pulses for 15 min, despite otherwise stable measures
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of perfusion, reflecting falling cortical microvascular haemoglobin concentration and oxygenation
minutes before PEA arrest. This result is presented on Figure 5b. Even though it is a single subject
study, this suggest that TD-NIRS might provide the means of detecting PEA arrest, by monitoring
cortical oxygenation.
Finally, Liebert and colleagues [96] and Weigl and colleagues [97] investigated the possibility
to use DCE-TD-NIRS to confirm brain death. Using an in-house developed multichannel TD-NIRS
systems (ID: 17 in Table 2), different stages of cerebral perfusion disturbances were compared in three
groups that included controls, patients with post-traumatic cerebral oedema, and patients with brain
death. The authors reported that DCE-TD-NIRS was feasible in the demanding ICU environment and
had promising initial results. However, at its current stage of development, the accuracy of the method
did not reach the high standards required for brain death confirmation.
3.5. Psychiatry and Cognitive Impairement
Another field of clinical application of TD-NIRS is psychiatry, in which NIRS is used to evaluate
functional brain activation in different neuropsychiatric disorders, notably in schizophrenic disorders,
and normal and pathological aging [12].
In the context of schizophrenia, we found two publications that used Hamamatsu TD-NIRS
systems to provide baseline measurement of haemoglobin concentration, tissue saturation and optical
path length in this group of patients. In these studies, fNIRS was also performed but using a CW-NIRS
system. We will therefore only report the TD-NIRS results. Firstly, Shinba and colleagues [98] used
TD-NIRS to investigate the frontal lobe dysfunction in schizophrenia. The authors reported no
significant difference in path length between the control group and schizophrenic group. However,
in some subjects, the path length was different from the mean value of the group by more than 20%,
highlighting the importance of a subject specific path length in order to retrieve accurate quantitative
values of the change of the haemoglobin concentrations. Hoshi and colleagues [99] investigated the
resting hypofrontality in patients with schizophrenia. They reported that the [HbT] decrease was
related to the duration of illness, and it was not observed in patients whose duration of illness was less
than 10 years. The authors concluded that despite the fact that resting hypofrontality is a chronically
developed feature of schizophrenia, this does not necessarily represent frontal dysfunction, but may
reflect anatomical and/or functional changes in frontal microcirculation.
On the other hand, several studies addressed the issue of cognitive impairments and aging using
Hamamatsu systems. Harada and colleagues [100] compared the haemoglobin concentration measured
by a TRS-10 system, and the cerebral activity, measured by a CW-NIRS system, of the prefrontal cortex
between 14 young adults and 14 elderly adults while driving. The main finding regarding the TD-NIRS
results for this study was that the concentrations of all forms of haemoglobin in elderly adults were
lower compared to young adults.
Two papers [101,102] reported the use of a TRS-20 system to evaluate the effect of cosmetic therapy
on prefrontal cortex (PFC) activity in 61 elderly females. The [HbT] and StO2 were evaluated before
and after a three-month program of cosmetic therapy. Murayama and colleagues [103] used a TRS-21
system to investigate the relationship between cognitive function and haemoglobin concentration
and tissue saturation of the prefrontal cortex (PFC) during rest in 113 elderly adults. The authors
quantified cognitive functions using the Mini-Mental State Examination (MMSE) score and the Touch
M score, which evaluates working memory function semi-automatically on a touchscreen. A significant
positive correlation between the MMSE scores and StO2 was found together with a significant positive
correlation between Touch M scores and baseline concentrations of [HbO2], [HbT] and StO2. It is
worth noting that the authors reported that the main advantage of TD-NIRS in that study was to
measure absolute information at rest; allowing them, therefore, to assess cognitive function without
any task (i.e., fNIRS using CW-NIRS). Oyama and colleagues [104] investigated the possibility of using
the haemoglobin concentration and StO2 information acquired with a TRS-20 system to predict the
MMSE score of a group of 202 elderly people. The MMSE was conducted first and then TD-NIRS
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measurement was performed. The authors found using a deep neural network (DNN) that the StO2
and the optical path lengths contributed to the prediction of the MMSE score.
Finally, two publications by Sakatani and colleagues [105] and Nakano and colleagues [106]
investigated the effects of two drugs on the improvement of cognitive function using a TRS-20 system.
In these two studies, the ability of TD-NIRS to measure absolute haemoglobin concentration and StO2
were crucial, since the measurements were taken several weeks apart.
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The decrease in StO2 can be seen 15 min prior to the arrest. Extracted from [95]. (c) Illustration of a 
measurement from [86], on a patient with an internal carotid artery (ICA) occlusion on the affected 
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the influence on the bolus passage are shown schematically on the right diagram, with the affected 
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Figure 5. Example of the data produced by TD-NIRS systems. (a) Coronal slices of tomographic images
of the blood volume and the StO2 of a baby who had a left ventricular haemorrhage. The haemorrhage
can be seen as an increase in blood volume and a decrease in oxygen saturation. Extracted from [69].
(b) StO2 and haemoglobin concentration ([tHb]) in a patient with septic shock during the hour prior to
a pulseless electrical activity arrest and cardiopulmonary resuscitation (CPR). The decrease in StO2
can be seen 15 min prior to the arrest. Extracted from [95]. (c) Illustration of a measurement from [86],
on a patient with an internal carotid artery (ICA) occlusion on the affected side and a crossflow over
the anterior communicating artery (ACoA). The anatomical situation and the influence on the bolus
passage are shown schematically on the right diagram, with the affected hemisphere shown in black
colour and the unaffected one shown in light grey. The left side of the figure compares the conventional
CW-NIRS based approach, which is represented by the time-integrated signal Ntot to the moment
TD-NIRS approach based on the a alysis of variance. The colours of the bolus curves correspond the
diagram (black: affected hemisphere, light grey: unaffected hemisphere). In the CW-NIRS approach,
the bolus curves differed only slightly. In contrast, in the TD-NIRS approach, the variance signals
showed a significant difference between the hemispheres. (d) Example of brain activity of a pati nt
with locked-in syndrome during mental imagery (MI), from [107]. The “rest” period corresponds to
data acquired without MI activation and is presented as a reference for the contrast observed during
the question periods. If the answer was “Yes” the patient was asked to perform a MI task (i.e., play
tennis). If the answer was “No”, the patient was asked to rest. The grey boxes indicate the response
period. One can see that the patient responded “yes” to two questions. At the time of this study, the
patient had regained limited eye movement, so those responses could be confirmed.
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3.6. Peroperative Care
It has been demonstrated that the use of NIRS to monitor the level of anaesthesia could lead to
better postoperative cognitive performance of the patient [108].
In a peroperative context, Kacprzak and colleagues [109] evaluated the application of TD-NIRS
to monitor cerebral oxygenation during carotid surgery. The authors used an in-house developed
multichannel TD-NIRS system (ID: 15 in Table 2) on a group of 16 patients with atherosclerotic disease
and monitored them during routine carotid endarterectomy surgery. The authors reported that the
changes in the haemoglobin signals, as estimated from intracerebral tissue, are very sensitive to
clamping of the internal carotid artery, whereas its sensitivity to clamping of the external carotid
artery is limited. This is a good indicator that the TD-NIRS method used in this paper can achieve
in-depth selectivity.
Furthermore, seven studies using Hamamatsu systems were reported in a peroperative context.
Ohmae and colleagues [110] reported the monitoring of cerebral circulation during cardiopulmonary
bypass surgery using a TRS-10 system. In this study, 23 patients who underwent coronary-artery
bypass surgery were evaluated reporting that TD-NIRS can be used to follow brain oxygenation during
cardiac bypass surgery. Moreover, the authors reported a large fluctuation of the mean optical path
length among patients. The authors also reported that the inter-patient variability of saturation was
low compared to that of the haemoglobin concentrations. This finding was also recently reported in
healthy volunteers [82]. In another study, Kakihana and colleagues [111] also monitored the cerebral
tissue saturation of patients undergoing a cardiac surgery requiring a cardiopulmonary bypass using
a TRS-10 system. The jugular venous oxygen saturation (SjvO2) was also monitored. Moreover,
postoperative cognitive dysfunction (POCD) was evaluated using the MMSE before and seven days
after the operation. It was found that there was no significant difference between the SjvO2 and StO2 in
patients without POCD, but that those two values were significantly different in patients with POCD.
Therefore, the combination of SjvO2 and cerebral StO2 might help predict the occurrence of POCD.
Lastly, Satao and colleagues [112] also used a TRS-10 system to investigate the depth-dependence of
haemoglobin concentration changes during carotid endarterectomy (CEA) in eight male patients with
symptomatic carotid stenosis during CEA surgery reporting brain specificity of the TD-NIRS.
Additionally, two studies using TRS-20 systems investigated the cerebral oxygenation of pregnant
women during child delivery. Yamazaki and colleagues [113] reported cerebral oxygenation, on the
PFC, of eighteen pregnant women during caesarean section, reporting that in a case of placenta previa,
massive bleeding immediately decreased cerebral StO2. Suzuki and colleagues [114] reported the
cerebral [HbT] in pregnant women in delivery. They showed difference between normotensive and
hypertensive women with or without epidural anaesthesia. Moreover, a decrease in cerebral [HbT] in
the hemi-prefrontal lobe in a woman 2 h after the onset of haemorrhagic stroke in labour could also be
detected. This reinforces the possibilities of using TD-NIRS in the context of child delivery.
Finally, Fujisaka and colleagues [115] using the latest TD-NIRS device developed by Hamamatsu
(a two-channel tNIRS-1) reported in one patient a decrease in brain [HbT] and StO2 during circulatory
arrest in cardiac surgery.
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Table 3. Table of the literature review of the use of TD-NIRS for clinical brain monitoring.
Publication Year
Patients
N = P (C)
P: Patients,
C: Controls
Apparatus
(ID) Method
Reported Quantities
Perfusion [HbO2] [HHb] [HbT] StO2 µa µ′s
Path
Length OtherDCS ICG
Nenonates (number of studies = 19)
Hintz et al. [62] 1998 N = 1 (0) In-house (6) DOT x
Hintz et al. [63] 1999 N = 6 (0) In-house (6) DOT x
Hintz et al. [64] 1999 N = 6 (0) In-house (6) DOT x
Benaron et al. [65] 2000 N = 2 (0) In-house (6) DOT x x
Hintz et al. [64] 2001 N = 2 (0) In-house (6) DOT x x x
Hebden et al. [70] 2002 N = 3 (0) In-house (7) DOT x x x x
Hebden et al. [71] 2004 N = 1 (0) In-house (7) DOT x x x x
Ijichi et al. [80] 2005 N = 22 (0) TRS-10 (1) Fitting x x x x x x x
Austin et al. [72] 2006 N = 24 (0) In-house (7) DOT x x x
Gibson et al. [69] 2006 N = 6 (0) In-house (7) DOT x x x x x
Hoshino et al. [79] 2010 N= 1 (0) TRS-10 (1) Fitting x x x x
Koyano et al. [75] 2013 N = 19 (0) TRS-10 (1) Fitting x x x x x x x
Fujioka et al. [77] 2014 N = 72 (0) TRS-20 (1) Fitting x x
Ishii et al. [76] 2014 N = 87 (0) TRS-20 (1) Fitting x x
Nakamura et al. [78] 2015 N = 11 (0) TRS-10 (1) Fitting x x
Dempsey et al. [73] 2015 N = 1 (0) In-house (8) Moments x
Spinelli et al. [81] 2017 N = 33 (0) In-house (9) Fitting x x x x x x
Giovannella et al. [59] 2018 N = 21 (0) In-house (10) Fitting x x x x
Dempsey (PhD thesis) [74] 2018 N = 5 (0) In-house (8) Moments x
Stoke assessment (number of studies = 8)
Liebert et al. [84] 2005 N = 2(2) In-house (11) Moments x
Yokose et al. (a) [90] 2010 N= 14 (11) TRS-10 (1) Fitting x x x x
Yokose et al. (b) [89] 2010 N= 10 (0) TRS-10 (1) Fitting x x x x
Leistner et al. [87] 2011 N =11 (0) In-house (13) Moments x
Steinkellner et al. [86] 2012 N =10 (0) In-house (12) Moments x
Liebert et al. [85] 2012 N = 2 (2) In-house (11) Moments x
Sato et al. [91] 2018 N = 5 (0) TRS-20 (2) Fitting x x x x x
Giacalone et al. [88] 2019 N = 47 (35) In-house (14) Fitting x x x x
Traumatic brain injury (TBI) assessment (number of studies = 3)
Weigl et al. [58] 2014 N = 26 (9) In-house (15) Moments x
Highton et al. [93] 2016 N = 21 (0) TRS-20 (2) Fitting x x x
He et al. [60] 2018 N = 7 (0) In-house (16) Fitting x x
Brain assessment in death (number of studies = 4)
Liebert et al. [96] 2014 N = 35(NA) In-house (17) Moments x
Lanks et al. [94] 2017 N = 11 (0) NIRO-TRS1 (5) Fitting x x
Lanks et al. [95] 2018 N = 1 (0) NIRO-TRS1 (5) Fitting x x x x
Weigl et al. [97] 2018 N = 28 (9) In-house (17) Moments x
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Table 3. Cont.
Publication Year
Patients
N = P (C)
P: Patients,
C: Controls
Apparatus
(ID) Method
Reported Quantities
Perfusion [HbO2] [HHb] [HbT] StO2 µa µ′s
Path
Length OtherDCS ICG
Psychiatry (number of studies = 9)
Shinba et al. [98] 2004 N = 13 (10) TRS-10 (1) Fitting x x
Hoshi et al. [99] 2006 N = 14 (16) TRS-10 (1) Fitting x
Harada et al. [100] 2007 N = 14 (14) TRS-10 (1) Fitting x x x
Sakatani et al. [105] 2014 N = 34 (0) TRS-20 (2) Fitting x x
Sakatani et al. [101] 2015 N = 61 (0) TRS-20 (2) Fitting x x x
Machida et al. [102] 2016 N = 61 (0) TRS-20 (2) Fitting x x x
Nakano et al. [106] 2016 N =20 (0) TRS-20 (2) Fitting x x x x
Murayama et al. [103] 2017 N = 113 (0) TRS-21 (3) Fitting x x x
Oyama et al. [104] 2018 N = 202 (0) TRS-21 (3) Fitting x x x x x
Peroperative care (number of studies = 7)
Ohmae et al. [110] 2007 N = 33 (0) TRS-10 (1) Fitting x x x x x x x
Sato et al. [112] 2007 N = 7 (0) TRS-10 (1) Fitting x x x x
Kakihana et al. [111] 2010 N = 10 (0) TRS-10 (1) Fitting x
Kacprzak et al. [109] 2012 N = 16 (0) in-house (15) Moments x x
Yamazaki et al. [113] 2013 N = 18 (0) TRS-20 (2) Fitting x
Suzuki et al. [114] 2015 N = 80 (0) TRS-20 (2) Fitting x x x x
Fujisaka et al. [115] 2016 N = 1 (0) tNIRS-1 (4) Fitting x x
Others (number of studies = 2)
Visani et al. [116] 2015 N = 12 (10) In-house (9) Gating x x
Abdalmalak et al. [107] 2017 N = 1 (0) In-house (18) Moments x x
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3.7. Others
Visani and colleagues [116] reported the haemodynamic and neuronal time course to unilateral
hand movement in 10 patients with cortical myoclonus, a pathology that triggers sudden, brief,
involuntary muscle jerks, compared with 12 healthy volunteers. This particular study was highly
multimodal with simultaneous EEG-fMRI and EEG-TD-NIRS measurements. An in-house developed
multimodal TD-NIRS system (ID: 9 in Table 2) was used together with the time-gated approach in
order to enhance that brain sensitivity. The authors reported a good agreement between the TD-NIRS
and fMRI findings, both for controls and patients, and showed reduced hemodynamic changes in
patients compared to controls.
Finally, it is known that NIRS can be used within a brain computer interface framework to allow
the use of brain activity to control computers or other external devices [117]. In a clinical context, this
can be used to communicate with patients with locked-in syndrome. Abdalmalak and colleagues [107]
reported the ability to successfully communicate with a functionally locked-in patient suffering from
Guillain–Barré syndrome. At the time of the study, the patient had regained limited eye movement,
which could be used to confirm the TD-NIRS findings. The hemodynamic response to a motor imagery
(MI) activity was measured using an in-house developed multichannel TD-NIRS systems (ID: 18 in
Table 2) and using the methods of moments to quantify the changes in µa to extract the changes in
[HHb] and [HbO2]. The subject was asked to answer three questions: (1) confirming his last name,
(2) whether he was in pain, and (3) if he felt safe. He was instructed to stay relaxed if he wanted to
answer “no” or to perform a tennis imaginary task if the answer was “yes”. The brain activation
pattern successfully predicted the correct answers, evaluated by eye movement, to the three questions
(see Figure 5d). Moreover, the metrics presented in this paper were in accordance with a previous
study, using the same system, on healthy volunteers [118].
4. Discussion
We have summarized the clinical application of TD-NIRS and reported its use (1) in the neonatology
unit to follow neonates with various conditions, (2) in the ICU to monitor stroke or TBI patients, or
to communicate with patients with locked-in syndrome, (3) in the operating room to follow brain
oxygenation during surgery, and (4) in more “standard” neuroscience environments for studies focusing
on patients with psychiatric disorders.
Historically, the first clinical application of TD-NIRS was in imaging the brain of premature infants;
in particular obtaining 3D tomographical images of their brains in the neonatal intensive care unit.
The 17% of TD-NIRS publications exploring TD-DOT are only focused on neonates. However, optical
brain tomographs require resolving significant hardware and software challenges, and after a prolific
number of publications in early 2000, this field has been less active on the clinical side even though
methodological developments are still being made. The reduction in activity might also be explained
by the significant improvements made by CW-NIRS-DOT [61].
Most of the TD-NIRS instruments used in clinical applications are multi-channel (81% of the
TD-NIRS). Multichannel systems can probe both hemispheres at the same time, which is very important
when a comparison is needed between hemispheres. On the other hand, some specific clinical
applications, such as in peroperative care where the brain responses are global, do not require
monitoring of several brain locations.
The other interesting metric of this review is that the distribution between commercial and
in-house developed system was fairly balanced, with 52% of papers reporting commercial system use.
However, it is worth mentioning that only Hamamatsu can provide commercial TD-NIRS systems, and
that most of the work reported with these systems was originating from Japan. The use of three different
versions of their research systems has been reported here (TRS-10/20/21). The use of a NIRO-TRS1
have also been reported, although it is worth noting that it is a research device which is not available
for sale. Lastly, we can note that the tNIRS-1 has been approved for use as a medical device in Japan
but has not obtained approval outside Japan as of March 2019 (Hamamatsu personal communication).
Appl. Sci. 2019, 9, 1612 19 of 31
Nevertheless, this approval in Japan is a great step towards the translation of the technique in the clinic.
Indeed, the limited availability of these clinically-approved commercial systems is undoubtfully one of
the main pitfalls of TD-NIRS, hindering its use in the hospital.
Regarding the data produced by TD-NIRS systems, it has been seen that a variety of information
can be retrieved, as illustrated in Figure 5. Information could be extracted about (1) the absolute optical
properties of tissue and path length; (2) the absolute value of haemoglobin and tissue saturation, either
as a snapshot tomographic image, or as a time-course at specific locations to follow spontaneous
changes, or changes due to a brain activation; (3) the in-depth kinetics of an ICG bolus time to assess
perfusion; and (4) the perfusion measured by a DCS system and calibrated with a TD-NIRS system.
In order to produce this information, different processing methods of the TPSF were used. It seems
that the fitting approach is the most widespread in order to extract the optical properties of tissues.
This is partly because this method is the one implemented in the Hamamatsu systems. When using
in-house instruments, the moment method tends to be used, especially when ICG is used. Indeed, in
the case of bolus tracking, the moments can be used directly to follow the kinetics of the contrast agent.
Moreover, the different depth-sensitivity of the moments enables the bolus to be tracked in-depth. To
date, there is no consensus on what the best method to extract the TPSF information content is, and it
might also depend on the application. This open issue still needs to be evaluated but we can report
that new methodological developments might help in this (see next section).
All of these different clinical applications require us to take advantages of the possibility of
TD-NIRS to measure absolute values of brain tissue saturation and haemoglobin concentration, to
compare either patients with controls, injured and less injured hemispheres, or the same patient over
time. In all situations, TD-NIRS showed itself relatively easy to use and functionally robust. Even
though TD-NIRS has the reputation of requiring bulky instruments, most of the instruments are
transportable and useable at the patient bedside, without disrupting patient care.
Indeed, even though a large number of these clinical applications can be done using CW-NIRS
systems, the inability of such instruments to interrogate the absorption and scattering properties of
the brain tissue will affect their accuracy. This has been for example demonstrated in [93], where a
modification of the scattering properties of TBI patients were reported, or in [91] where modification of
the optical path length between the affected and unaffected hemispheres of stroke patients were noted.
The use of TD-NIRS to acquire insight in anatomical differences of patients is, thus, an interesting
path to explore and could justify their use even further. Moreover, the optical properties information
extracted from TD-NIRS system could also be used to strengthen the application of the CW-NIRS, by
providing more accurate information of path length, as has been seen in the applications in psychiatry.
Lastly, it is worth mentioning that even though TD-NIRS can provide absolute information about HHb
and HbO2 concentrations, the extraction of the absolute properties and then of the concentration of the
chromophore are also subjected to assumptions that also limit the accuracy of TD-NIRS. Indeed, the
fitting approach is usually based on the solution of the DE in simple homogeneous geometries which
do not reflect the complexity of the head architecture [119]. Moreover, one major assumption that
needs to be made to calculate the chromophore concentration from the absorption coefficient, is the
number of chromophores considered. Indeed, it is usually assumed than HHb, HbO2 and water are
the only significant absorbers, with the water content most often fixed to a certain value (i.e., usually
80% for adults) [41]. However, it is likely that this water content is highly subject-dependent, notably
due to the variability of the thickness of skin, skull and CSF and that other chromophores might need
to be considered [120]. New methodological and hardware developments are addressing these issues,
and these will be detailed in the next section.
We could also see that by using complementary techniques, like DCE-TD-NIRS or TD-NIRS and
DCS, it was possible to assess brain perfusion. In particular, the accuracy of the assessment of brain
perfusion with the DCE technique, although achievable with a CW-NIRS system, is greatly improved
by using TD-NIRS instrumentation, notably because it helps to distinguish between the extra- and
intra-cerebral tissues. Having the possibility to continuously assess the CBF together with the brain
Appl. Sci. 2019, 9, 1612 20 of 31
oxygenation, at the bedside, is a true benefit because it can give information about both oxygen delivery
and demand, facilitating the identification of the underlying issue. The novel development in that area
(see next section) will probably contribute greatly to the adoption of TD-NIRS in the clinic.
Finally, TD-NIRS proved to be able to be easily integrated with other modalities, and that even
simultaneous imaging was possible with MRI, MEG or EEG. As the use of multi-modality imaging
in modern medicine is growing, because it helps to get a clearer picture of a patient condition, this
capability is also a great strength for TD-NIRS. In the context of brain imaging, this possibility can
be used to give a complete picture of the link between anatomical and functional disorders. From
a functional point of view, it has the potential to show the links between the neuronal and vascular
components of various conditions.
5. Current Developments in TD-NIRS and Clinical Pertinence
We have reviewed the current clinical applications of TD-NIRS for brain monitoring. The present
review shows that current generation of TD-NIRS can be used in a clinical environment on patients
with different pathologies. However, this technology is still not at its final stage and current progress
made in different areas of TD-NIRS might help to push even more its use in the clinic. In the next
sections, we will highlight the major novelties in TD-NIRS, which we think will help to promote its
growth as a clinical tool.
5.1. Toward TD-NIRS Standardisation
The main reported drawback of NIRS is the lack of standardisation. Indeed, different systems can
use different wavelengths, different source or detector types, or even different theoretical models. The
use of TD-NIRS makes the standardisation of the NIRS measurement easier by extracting absolute
information. Recently, new protocols have emerged in order to compare the results of different
TD-NIRS systems. We can cite the MEDPHOT protocol [121], consisting of a set of calibrated phantoms
that can be used to test the accuracy of the measured absorption and reduced scattering coefficient; the
basic instrumental performance (BIP) protocol [122], consisting of a series of tests that enable us to
compare the raw characteristics of different TD-NIRS instruments; and the nEUROPt protocol [123],
that addresses the characteristics of optical brain imaging to detect, localize, and quantify absorption
changes in the brain. The application of those protocols enables the community to qualitatively
and quantitatively compare TD-NIRS instruments, independently of their raw characteristics or
independently of the model used. Thus, large-scale clinical studies, even with slightly different
TD-NIRS instruments, could be designed.
5.2. Instrumental Progress
In recent years, a great deal of progress has been made in TD-NIRS instrumentation. One of
the issues that has to be addressed is to reduce the footprint of the instruments, often considered as
bulky. Indeed, even though current systems are useable in a clinical context, the current generation are
often mounted on racks which are significantly larger than typical CW-NIRS systems [57]. Reducing
the footprint of instruments is therefore crucial in a clinical context where space is limited. Figure 6
illustrates newly developed hardware that illustrates the miniaturisation of TD-NIRS hardware
by showing recently developed elements like miniaturized laser sources or detectors [124,125] no
larger than few millimetres. Using these newly developed components, a compact two channel, two
wavelength system which fits in a box has been reported, as presented in Figure 6e [126]. This illustrates
well the future possibilities of TD-NIRS with instrumental footprints comparable to CW-NIRS systems
already used in the clinic. Moreover, these new components have the great advantage of being cheap,
which will reduce the overall cost of a TD-NIRS system, facilitating even more its implementation.
Another line of developments of TD-NIRS systems in order to make the measurement easier to
handle for medical staff is non-contact imaging. Few non-contact TD-NIRS system are reported in
the literature [127]. Such systems smooth the user experience since no expertise is required in fibre
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positioning. However, such imaging systems would be limited to specific applications, probably to the
prefrontal cortex, since hairy regions are particularly difficult to image with such systems. Nevertheless,
it is an avenue that needs to be explored. Other systems based on non-fibre emission and detection, in
contact with the skin of the patient, have also been reported [128]. These systems not only remove the
optical fibres, but also increase the SNR by reducing light losses.
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Figure 6. Examples of new TD-NIRS instrumentation. (a) Laser diode for compact systems (from [124]).
(b) A compact probe holder based on a SiPM detector. No optical fibre is needed, and the detector
is placed in direct contact with the skin. Extracted from [128]. (c) Compact SiPM detector. Extracted
from [129]. (d) Fibreless TD-NIRS system. Extracted from [130]. (e) Compact all-in-one single channel
TD-NIRS system. Extracted from [131].
5.3. Development of New Methodologies
In parallel with these technical developments, new methodologies have emerged that could
be relevant in clinical applications, by improving the data quality, extracting more information or
facilitating the operation of TD-NIRS system. For example, one of the particularities of TD measurements
is the need to acquire an IRF to calibrate the measurement. This operation is time-consuming and is
not always suitable in a clinical environment. A recent work by Milej and colleagues [132] reported a
method based on a multi-distance TD-NIRS measurement that eliminates the need for the IRF. The
removal of this extra measurement step would definitely benefit its adoption by the clinical community.
Other new methodological developments arise from hardware improvements. For example,
the development of the new sources and detectors is not only beneficial in terms of miniaturisation,
but also improves the quality of the raw signal. Indeed, one of the drawbacks of the TD-NIRS
instrumentations over CW-NIRS systems is that it is more difficult to obtain a TPSF with a good
SNR [49]. However, the newly developed sources and detectors can be used to perform a null
source-detector distance measurement [133]. This approach is based on the fact that, unlike the CW
technique, the source-detector distance does not influence the penetration depth in a TD measurement.
Therefore, the sources and detectors can be positioned close together to increase the number of
photons acquired, which greatly increases the SNR. Recently, Pifferi and colleagues reviewed the new
developments in the concept and hardware of TD-NIRS [134], and showed not only that the SNR of
TD-NIRS measurements would not be a problem anymore, but also that the new instrumentation
and methodologies can help to improve the resolution, the contrast, or the depth sensitivity of the
TD-NIRS measurement. Thus, measurements to assess structures deeper than 5–6 cm are reportedly
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possible [133]. Although these possibilities are still to be demonstrated practically, this could allow
access to subcortical regions which would be a considerable asset in fields like TBI or stroke monitoring.
Another exciting development is the broadband or multi-wavelength TD-NIRS, which enables
true spectroscopic analysis. Indeed, the systems presented in this review rarely use more than three
wavelengths, which is enough to assess the haemoglobin content. However, being able to quantify
other chromophores, like water or lipids, can help to increase the accuracy of the oxygen saturation,
by actually quantifying contributions that were either assumed (i.e., water content) or not taken into
account (i.e., fat content). Sekar and colleagues [120] have reported the development of a TD-NIRS
instrument with a broadband capability, acquiring data from 600–1350 nm. This system has a slow
acquisition speed (i.e., minutes per spectra) but could still be used to assess the brain status of
patients at the bedside. Lange and colleagues [135] reported the development of a multiwavelength
TD-NIRS system, capable of acquiring data at a rate compatible with a typical hemodynamic response,
with 16 wavelengths in the range 650 to 870 nm. This system has been designed in order to target
haemodynamic as well as CCO. This capability could be of interest in the clinic, as CCO has been
shown to be a potential marker of brain injury in HIE [136]. In the context of HIE, some interesting
work has been reported recently, using a TD-NIRS instrument to non-invasively monitor the brain
temperature [137]. The method has been tested on piglet with promising results. As hypothermic
therapy is now the standard treatment for neonates, but optimal protocols are yet to be established
(i.e., in terms of duration and depth of treatment, for example) [138], the ability to monitor brain
temperature non-invasively at the bedside would certainly be another argument in favour of the
clinical use of TD-NIRS.
The last big methodological development, which was discussed in an earlier section, was the
ability to measure brain perfusion. It has been shown that the use of TD-NIRS in combination with DCS
could improve the data quality of the BFI retrieved by the DCS. However, the current DCS measurement
suffers from the same drawback as CW-NIRS, being the contamination of the signal by extracerebral
layers. Baker and colleagues in 2015 used a combination of short and long source-detector distance
DCS with pressure modulation (head blood pressure cuff) to remove extracerebral contributions in
the DCS signal [139]. However, a recent development called TD-diffuse correlation spectroscopy
(TD-DCS) has been reported, allowing DCS measurement in the TD regime [137]. Thus, through the
use of time gating, an in-depth measurement of the BFI became possible, improving the accuracy of
the measurement of the cerebral blood flow [138]. Finally, it is also worth mentioning that while most
of the DCS systems reported in the literature only have one channel, Delgado-Mederos and colleagues
have recently demonstrated a dual channel DCS allowing bi-hemispheric measurements in stroke
patients [140]. This illustrates the potential development of multi-channel DCS.
Finally, as seen in this review, imaging patients differs from imaging healthy subjects because
normal tissue configuration cannot always be assumed. A recent study by Ancora and colleagues [141]
showed that it might be possible to use TD-NIRS to evaluate the progression of brain atrophy in
patients. Indeed, the late photons of the TPSF seems to be sensitive to the thickness of the CSF layer.
However, this simulation study showed that this technique would require the acquisition of photons
with very long arrival time (>2.5 ns) with a good enough SNR. In that sense, the newly developed
detector might help to push this methodology forward.
On the other hand, the structural changes consecutive to some pathologies also suggests that
classical models might not work in all cases. However, as it has been seen, NIRS is extremely well-suited
for multimodal imaging. Therefore, combining anatomical imaging with NIRS allows for model-patient
specific geometry that will increase the NIRS accuracy [142]. Here, the progress being done in terms of
Monte-Carlo modelling, especially in terms of calculation speed [143], unlock new possibilities for it to
be used in real-time at the bedside.
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6. Conclusions
The use of NIRS technology has drawn a great deal of attention in the last four decades, due to its
potential to continuously monitor the brain tissue physiology non-invasively, in real-time and at the
patient bedside. However, the lack of reference values of brain tissue oxygen saturation coupled with
the inherent limitations of the commonly-used CW-NIRS systems, in terms of accuracy and capability
to differentiate non-cortical and cortical tissues, have hindered the popularity of NIRS. On the other
hand, TD-NIRS systems have not been as popular because of their complexity and the lack of system
availability commercially, with only one company selling instruments. However, in recent years, a few
publications have reported successful clinical work using TD-NIRS. Indeed, this technique presents
the unique advantage of measuring the distribution of the time of flight of photons. The amount of
information contained in those DTOFs enables us to retrieve the optical properties (µa and µ′s) of
the tissue, even with only one channel. Having access to the absolute optical properties allows us to
retrieve absolute concentration of haemoglobin and tissue saturation that are more robust than the
those acquired via CW-NIRS systems, which only assume a constant, non-patient-specific µ′s.
Moreover, it has also been shown that µ′s could be used as a biomarker of TBI and that it was
possible to follow the development of brain atrophy, for example in patients with neurodegenerative
disease, by looking at the distribution of the late photons of the TPSF. These works reinforce the
importance of the information acquired with TD-NIRS, which has the potential to not only measure
brain oxygenation accurately, but also to give some insights to the brain tissue structure.
It is worth mentioning that TD-NIRS can be coupled with DCE and/or DCS in order to monitor
brain perfusion. The use of the moments allows DCE-TD-NIRS to extract an in-depth measure of
the brain perfusion, improving the accuracy of its estimation over DCE-CW-NIRS. Additionally,
combining DCE-TD-NIRS with DCS allows us to continuously monitor the brain perfusion, reported
in physiological units, which facilitates better clinical interpretation.
Finally, both the cost and the size of the TD-NIRS instruments have repeatedly been reported as
the main disadvantages of this technique. However, the recent instrumental developments allow the
reduction of both the cost and the size of the TD-NIRS systems. Therefore, we have no doubt that
these improvements, coupled with the great possibilities offered by TD-NIRS to extract accurate brain
oxygenation information, together with insights of the brain tissue structure, will enhance and further
facilitate the popularity of TD-NIRS in clinical environments.
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